Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils

Clinica Terapeutica

Volumn 157, Issue 1, 2006, Pages 19-24

  Zucca, A ^a   Brizzi, S ^a   Riccioni, R ^a   Azzara A ^a   Ghimenti, M ^b   Carulli, Giovanni ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Actin; Actin polymerization; Filgrastim; Lenograstim; Neutrophils; rhG CSF

Indexed keywords

F ACTIN; MYELOSTIM; PHALLOIDIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ACTIN; GRANULOCYTE COLONY STIMULATING FACTOR; POLYMER; RECOMBINANT PROTEIN;

ACTIN POLYMERIZATION; ADULT; ARTICLE; BLOOD DONOR; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN EXPERIMENT; MALE; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; CASE CONTROL STUDY; DRUG EFFECT; METABOLISM; MIDDLE AGED; STEM CELL MOBILIZATION;

ACTINS; ADULT; CASE-CONTROL STUDIES; FEMALE; FILGRASTIM; FLOW CYTOMETRY; GLYCOSYLATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; POLYMERS; RECOMBINANT PROTEINS;

EID: 33744762439     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ozer H, Armitage JO, Bennett CL, et al.: Update of reccomendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000; 18:3558-85
2. Carlsson G, Ahlin A, Dahllof G, et al.: Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol 2004; 126:127-32
3. Gross-Weege W, Weiss M, Schneider M, et al.: Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process. Intensive Care Med 1997; 23:16-22
4. Carulli G: Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and function. Haematologica 1997; 82:606-16
5. Carulli G, Minnucci S, Azzarà A, et al.: Granulocyte colony-stimulating factor increases CD32 (FcRII) expression and FcR-related functions. Haematologica 1995; 80:150-4
6. Azzarà A, Carulli G, Rizzuti-Gullaci A, et al.: Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis. Br J Haematol 1996; 92:161-8
7. Leavy PJ, Sellins KS, Thurman G, et al.: In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 1998; 92:4366-74
8. Spiekermann K, Emmendoerffer A, Elsner J, et al.: Altered surface marker expression and function of G-CAF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 1994; 87:31-8
9. Carulli G, Papineschi F, Benedetti E, et al.: Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy. Haematologica 1999; 84:281-3
10. Niggli V: Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 2003; 35:1619-38
11. Cicchetti G, Allen PG, Glogauer M: Chemotactic signaling pathways in neutrophils: from receptor to actin assembly. Crit Rev Oral Biol Med 2003; 13:220-8
12. Dunn CJ, Goa KL: Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings. Drugs 2000; 59:681-717
13. Bonig H, Silbermann S, Weller S, et al.: Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF) - results of a prospective randomised monocentre study. Bone Marrow Transplant 2001; 28:259-64
14. Martin-Christin F: Granulocyte colony-stimulating factors: how different are they? How to make a decision? Anticancer Drugs 2001; 12:185-91
15. De Arriba F, Lozano ML, Ortuno F, et al.: Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells. Br J Haematol 1997; 96:418-20
16. Kim IH, Park SK, Suh OK, et al.: Comparison of Lenograstim and Filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose therapy. Curr Med Res Opin 2003; 19:753-59
17. Azzarà A, Carulli G: Morphological features following G-CSF treatment. Haematologica 1997; 82:504-5
18. Azzarà A, Carulli, G, Rizzuti-Gullaci A, et al.: Lenograstim and Filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis. Am J Hematol 2001; 66:306-7
19. Carulli G, Minnucci S, Gianfaldoni ML, et al.: Interactions between platelets and neutrophils in essential thrombocythemia. Effects on neutrophil chemiluminescence and superoxide anion generation. Eur. J Clin Invest 1995; 25:929-38
20. Wallace PJ, Wersto RP, Packman CH, et al.: Chemotactic peptide-induced changes in neutrophil actin conformation. J Cell Biol 1984; 99:1060-5
21. Carulli G, Sbrana S, Minnucci S, et al.: Actin polymerization in neutrophils from patients affected by myelodysplastic syndromes. A flow cytometric study. Leukemia Res 1997; 21:513-8
22. Weiner OD: Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr Opin Cell Biol 2002; 14:196-202
23. Watts RG, Howard TH: Mechanisms for actin reorganization in chemotactic factor-activated polymorphonuclear leukocytes. Blood 1993; 81:2750-7
24. Torres M, Coates TD: Function of the cytoskeleton in human neutrophils and methods for evaluation. J Immunol Meth 1999; 232:89-109
25. Mattii L, Azzarà A, Fazzi R, et al.: Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA. Leukemia Res 2005; 29:1285-92
26. Anderson SI, Hotchin NA, Nash GB: Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. J Cell Sci 2000; 113:2737-45